Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer.
about
Decreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor outcome in breast cancer.Translating extranuclear steroid receptor signaling to clinical medicine.Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signalingCombination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer.Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sightERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerDiffusion weighted imaging evaluated the early therapy effect of tamoxifen in an MNU-induced mammary cancer rat modelPotential therapeutic benefit of combining gefitinib and tamoxifen for treating advanced lung adenocarcinoma.Membrane and nuclear estrogen receptor α collaborate to suppress adipogenesis but not triglyceride content.Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint.Estrogen regulates histone deacetylases to prevent cardiac hypertrophy.Acid-degradable core-shell nanoparticles for reversed tamoxifen-resistance in breast cancer by silencing manganese superoxide dismutase (MnSOD).Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me'.Estrogen receptor-β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis.Mitochondrial "power" drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer.Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy.Effect of tamoxifen and fulvestrant long-term treatments on ROS production and (pro/anti)-oxidant enzymes mRNA levels in a MCF-7-derived breast cancer cell line.The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio.Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors.Mitochondrial determinants of cancer health disparities.MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.SIRT3 Silencing Sensitizes Breast Cancer Cells to Cytotoxic Treatments Through an Increment in ROS Production.Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.Assay of Calcium Transients and Synapses in Rat Hippocampal Neurons by Kinetic Image Cytometry and High-Content Analysis: An In Vitro Model System for Postchemotherapy Cognitive Impairment.Visualization of breast cancer metabolism using multimodal non-linear optical microscopy of cellular lipids and redox state.
P2860
Q33648445-B35461FB-5FB8-4A5E-9258-B2FFF9CF3A73Q33692847-E186D344-00E8-43EE-97A9-875D459EAF8DQ33966915-381618A5-7DBF-406A-8176-8EB76FD97A6AQ33989940-87F684C4-EDD6-4864-A938-CCBDC6C287CFQ34010413-1463A5F5-2354-4666-A2EB-F7FA3E46CEA5Q34334131-51987A91-7536-433F-9B37-81E98560E052Q34735514-D5EBB003-2ECA-45CF-8757-0DD86B66D463Q35062108-1D6D26DD-4C32-49A4-98CF-BDE9F10069C0Q36385425-152811EA-DA7C-4284-8617-B4604F7544ADQ37371622-85A80C78-A24F-496E-82F3-525BFE3E7918Q37387804-A6327C0A-B14E-4ACA-B0BA-7F4EB1556EBFQ37706676-D5C6E4E1-C3A1-4FF6-96D7-DF18EAB5AF56Q38474990-3CB68856-BB98-4AF9-985B-C7762237058EQ38572516-B4C92B9F-B378-475E-83A6-0E14C170FD07Q38707608-341568EF-2E4F-423B-8DE4-343670F7C433Q38786015-C7C3F6F8-E187-4C53-ADD1-E95998D58558Q38851061-805FEA60-5C24-4D10-850B-2BAF422D7E56Q38861044-544655ED-89DE-4438-8F7A-D7D3099D1E13Q38978340-437B37B8-0FDA-41C9-B701-86C6B6FB33E2Q39294200-4054AD85-061E-4AAB-BF3F-440BFAE3F82CQ42706074-9BE6352E-4ACA-4255-9521-5024437B6E65Q46515900-32C6E5B1-CDC6-465C-8282-415EB6EF8A16Q47394260-CE3A023C-3A1F-4769-BA3C-F53D67DE37BFQ50882231-326AE203-2A61-4137-B8ED-F7D4F6000BDCQ52657362-97E974E1-57C5-4DB9-A2CE-F45B3B44F039
P2860
Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tamoxifen regulates cell fate ...... eceptor beta in breast cancer.
@ast
Tamoxifen regulates cell fate ...... eceptor beta in breast cancer.
@en
type
label
Tamoxifen regulates cell fate ...... eceptor beta in breast cancer.
@ast
Tamoxifen regulates cell fate ...... eceptor beta in breast cancer.
@en
prefLabel
Tamoxifen regulates cell fate ...... eceptor beta in breast cancer.
@ast
Tamoxifen regulates cell fate ...... eceptor beta in breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Tamoxifen regulates cell fate ...... eceptor beta in breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2012.335
P407
P577
2012-08-20T00:00:00Z